EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications

Tanveer A Tabish, Mian Zahid Hussain, Sevasti Zervou, William K Myers, Weiming Tu, Jiabao Xu, Irina Beer, Wei E Huang, Rona Chandrawati, Mark J Crabtree, Paul G Winyard, Craig A Lygate

Redox Biology · 2024-06 · 72 · 103144

DOI: 10.1016/j.redox.2024.103144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Redox Biology, 2024-06. Verfasst von Tanveer A Tabish und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation (BHF) Centre of Research Excellence, University of Ox…. Hauptthemen laut MEDLINE: Graphite, Nitric Oxide. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Department of Chemistry, University of York, Engineering and Physical Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nitric oxide (NO) is a key signalling molecule released by vascular endothelial cells that is essential for vascular health. Low NO bioactivity is associated with cardiovascular diseases, such as hypertension, atherosclerosis, and heart failure and NO donors are a mainstay of drug treatment. However, many NO donors are associated with the development of tolerance and adverse effects, so new formulations for controlled and targeted release of NO would be advantageous. Herein, we describe the design and characterisation of a novel NO delivery system via the reaction of acidified sodium nitrite with thiol groups that had been introduced by cysteamine conjugation to porous graphene oxide nanosheets, thereby generating S-nitrosated nanosheets. An NO electrode, ozone-based chemiluminescence and electron paramagnetic resonance spectroscopy were used to measure NO released from various graphene formulations, which was sustained at >5 × 10-10 mol cm-2 min-1 for at least 3 h, compared with healthy endothelium (cf. 0.5-4 × 10-10 mol cm-2 min-1). Single cell Raman micro-spectroscopy showed that vascular endothelial and smooth muscle cells (SMCs) took up graphene nanostructures, with intracellular NO release detected via a fluorescent NO-specific probe. Functionalised graphene had a dose-dependent effect to promote proliferation in endothelial cells and to inhibit growth in SMCs, which was associated with cGMP release indicating intracellular activation of canonical NO signalling. Chemiluminescence detected negligible production of toxic N-nitrosamines. Our findings demonstrate the utility of porous graphene oxide as a NO delivery vehicle to release physiologically relevant amounts of NO in vitro, thereby highlighting the potential of these formulations as a strategy for the treatment of cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GraphiteNitric OxideHumansNanostructuresPorosityNitric Oxide DonorsCell ProliferationCardiovascular DiseasesEndothelial CellsHuman Umbilical Vein Endothelial CellsMyocytes, Smooth Muscle

Substanzen

GraphiteNitric Oxidegraphene oxideNitric Oxide Donors

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation (BHF) Centre of Research Excellence, University of Oxford, Headington, Oxford, OX3 7BN, United Kingdom. Electronic address:…
  • School of Natural Sciences and Catalysis Research Centre, Department of Chemistry, Chair of Inorganic and Metal-Organic Chemistry, Technical University of Munich (TUM), Lichtenbergstraße 4, 85748, Garching, Germany.
  • Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation (BHF) Centre of Research Excellence, University of Oxford, Headington, Oxford, OX3 7BN, United Kingdom.
  • Centre for Advanced Electron Spin Resonance (CAESR), Inorganic Chemistry Laboratory, Department of Chemistry, University of Oxford, Oxford, OX1 3QR, United Kingdom.
  • Department of Engineering Science, University of Oxford, Oxford, OX1 3PJ, United Kingdom.
  • Department of Engineering Science, University of Oxford, Oxford, OX1 3PJ, United Kingdom; James Watt School of Engineering, University of Glasgow, Glasgow, G12 8QQ, United Kingdom.

Förderung

  • British Heart Foundation
  • Department of Chemistry, University of York
  • Engineering and Physical Sciences Research Council
  • University of Oxford John Fell Fund

Zitieren

APA

Tabish, T. A., Hussain, M. Z., Zervou, S., Myers, W. K., Tu, W., Xu, J., Beer, I., Huang, W. E., Chandrawati, R., Crabtree, M. J., Winyard, P. G., & Lygate, C. A. (2024). S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications. Redox Biology, 72, 103144. https://doi.org/10.1016/j.redox.2024.103144

Vancouver

Tabish TA, Hussain MZ, Zervou S, Myers WK, Tu W, Xu J, et al. S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications. Redox Biology. 2024;72:103144. doi:10.1016/j.redox.2024.103144

BibTeX
@article{Tabish2024,
  author = {Tabish, Tanveer A and Hussain, Mian Zahid and Zervou, Sevasti and Myers, William K and Tu, Weiming and Xu, Jiabao and Beer, Irina and Huang, Wei E and Chandrawati, Rona and Crabtree, Mark J and Winyard, Paul G and Lygate, Craig A},
  title = {S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications},
  journal = {Redox Biology},
  year = {2024},
  volume = {72},
  pages = {103144},
  doi = {10.1016/j.redox.2024.103144}
}
Kostenlos starten →